• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Iteos Therapeutics Inc (NQ: ITOS )

    9.685 -0.135 (-1.37%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 394,654
    Open 9.780
    Bid (Size) 9.010 (1)
    Ask (Size) 9.980 (12)
    Prev. Close 9.820
    Today's Range 9.620 - 9.900
    52wk Range 8.200 - 18.75
    Shares Outstanding 35,763,742
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    The One-Minute Market Report - Sunday, Sept. 22
    In this brief market report, we will take a look at the various asset classes, sectors, equity categories, exchange-traded funds, and stocks that moved the market higher, as well as the market segments... 
    Via Talk Markets
    Sky Harbour Group, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga

    Performance

    YTD
    -16.44%
    -16.44%
    1 Month
    -41.87%
    -41.87%
    3 Month
    -34.47%
    -34.47%
    6 Month
    -26.18%
    -26.18%
    1 Year
    -8.11%
    -8.11%

    More News

    Read More
    Nuvalent Flies On 'Multibillion-Dollar' Potential, While Iteos Crashes On Patient Deaths
    Via Investor's Business Daily
    Topics Death
    Exposures Death
    Crude Oil Surges Over 1%; Instil Bio Shares Plunge
    Via Benzinga
    Exposures Fossil Fuels
    iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    Recap: ITeos Therapeutics Q4 Earnings
    Via Benzinga
    Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    iTeos Announces Clinically Meaningful Objective Response Rate Observed at Every Dose in Follow-up Interim Analysis of GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients
    From iTeos Therapeutics Inc.
    Via GlobeNewswire
    iTeos to Participate in Upcoming Investor Conferences
    From iTeos Therapeutics Inc.
    Via GlobeNewswire
    iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024
    From iTeos Therapeutics Inc.
    Via GlobeNewswire
    ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q2 2024
    Via InvestorPlace
    iTeos Reports Second Quarter 2024 Financial Results and Provides Business Updates
    From iTeos Therapeutics Inc.
    Via GlobeNewswire
    iTeos Therapeutics Announces Appointment of David Feltquate as Chief Medical Officer
    From iTeos Therapeutics Inc.
    Via GlobeNewswire
    iTeos Announces First Patient Dosed in GALAXIES Lung-301 Phase 3 Study, Earning $35 Million in Milestones from GSK
    From iTeos Therapeutics Inc.
    Via GlobeNewswire
    iTeos and GSK Initiate GALAXIES Lung-301 Phase 3 Study, Assessing Belrestotug and Dostarlimab in Previously Untreated, Unresectable Locally Advanced / Metastatic PD-L1 Selected Non-Small Cell Lung Cancer
    From iTeos Therapeutics Inc.
    Via GlobeNewswire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q1 2024
    Via InvestorPlace
    Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Dow Jumps Over 100 Points; DNOW Posts Downbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
    From iTeos Therapeutics Inc.
    Via GlobeNewswire
    iTeos Therapeutics Announces $120 Million Registered Direct Offering
    From iTeos Therapeutics Inc.
    Via GlobeNewswire
    iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
    From iTeos Therapeutics Inc.
    Via GlobeNewswire
    ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q4 2023
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.